Keros is an inclusive company. We believe that diversity drives innovation.
At Keros, our mission is to deliver significant clinical benefit to a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-ß) family of proteins.
Keros is an inclusive company. We believe that diversity drives innovation.
Beam Therapeutics